Skip to main content
Clinical Trials/DRKS00029926
DRKS00029926
Not yet recruiting
Not Applicable

Sedation and analgosedation (PSA) in pediatric patients - evaluation of new procedure for the documentation of complications - PSA in pediatric patients - a new procedure for the documentation of complications

niversitätsklinikum des SaarlandesKliniken für Kinder- und Jugendmedizin0 sites700 target enrollmentJuly 29, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Documenataion of potential complications and of possible interventions during PSA of pediatric patients.
Sponsor
niversitätsklinikum des SaarlandesKliniken für Kinder- und Jugendmedizin
Enrollment
700
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 29, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum des SaarlandesKliniken für Kinder- und Jugendmedizin

Eligibility Criteria

Inclusion Criteria

  • All pediatric patients (age \< 18 years) at our institution (University Hospital of Saarland; Hospital for Children and Adolescents) with a need for PSA in the context of a diagnostic or interventional procedure.
  • \- Written consent by parents/legal guardian and by the capable patient (approx. \> 12 years) for analysis of the sedation protocol.

Exclusion Criteria

  • Age \> 18 years.
  • \- Missing written consent by parents/legal guardian and by the capable patient (approx. \> 12 years) for analysis of the sedation protocol.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Analgesia and sedation to guarantee painful venous access in children not intubated.
RBR-5gwknkHospital Universitario da Universidade de São Paulo
Active, not recruiting
Not Applicable
Analgo-sedative therapy in neurosurgical pediatric patients Ketamine plus midazolam versus Remifentanyl plus Midazolam - NDneurosurgical pediatric patients.MedDRA version: 9.1Level: LLTClassification code 10061268Term: Malignant nervous system neoplasm
EUCTR2006-003217-40-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Withdrawn
Phase 2
Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal MidazolamTraumatic Brain InjuryComputed TomographyProcedural Sedation
NCT01402596University of Sao Paulo
Not yet recruiting
Not Applicable
Sedation of paediatric patients with suspected mitochondrial disorder in painless diagnostic proceduresE71Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
DRKS00021631niversitätsklinikum Köln Klinik für Anästhesiologie und Operative Intenisvmedizin300
Active, not recruiting
Phase 1
Preanesthetic medication in pediatric patients: A comparison of midazolam, clonidine and dexmedetomidineIs there a difference in anxiety- and sedation-level, and in anesthesia induction compliance between the preanesthetics included in study, in pediatric patients? Can we prevent and reduce anxiety without causing negative cardiorespiratory effects by selected preanesthetic included in study, in TIVA in pediatric patients? Does the preanesthetic used in this study prevent and/or reduce pain, vomiting, shivering, events of emergence delirium and maladaptive behaviors, without prolonging recovery?Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2015-003676-70-SEorrbottens läns landsting